Nanoparticle-based gene therapy may hold promise for patients with asthma
News-Medical.net A new study has demonstrated a way to deliver a nanoparticle-based gene therapy, in order to repair lungs damaged by chronic allergic asthma and to reduce inflammation that causes asthma attacks. The potential therapy, tested in mice, may hold promise … |
View full post on asthma – Google News